Health research aims to find better ways to treat, prevent and cure disease.
This vital component of healthcare can take multiple forms and present a variety of risks and opportunities. Whether it is a clinical trial, secondary data research, research ethics board protocol review, or a material transfer agreement, we keep the aims of the study top of mind while advising researchers, funders, and health care organizations. We also advise on deidentification of data for research purposes, and questions of research versus quality.
Our services include:
Agreements - Material transfer, clinical trial, data sharing, basic science
Research ethics board advice
Research misconduct
Protocol reviews
Informed consents
Deidentified data
Connect with our team
Mary Jane Dykeman
Samara Starkman
Updated: Nov 16, 2022
Watch the video below as Carole Piovesan (INQ) with special guests Myriah Jaworski (Clark Hill) and Philip Dawson (Armilla A.I.) discuss 'The Regulation of AI Tools in the US and Beyond'.
They examined and identified proposed and passed laws regulating artificial intelligence in the U.S. The discussion unpacked specific trends in U.S. law, from the White House Blueprint for an AI Bill of Rights to pending or passed laws in New York City, Washington D.C., California and beyond.
Comments